We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
-
)
Barcelona is a thriving strategic hub for advanced therapies. At Advanced Therapies Europe 2025, the city becomes more t ... -
)
Get an exclusive first look at what’s in store for Advanced Therapies Europe 2025. This live webinar will explore the ke ... -
)
AI and machine learning have long promised to revolutionize the cell and gene therapy industry—but how much of that prom ... -
)
ArticleFrom Vision to Impact: How Marion Hitchcock Is Powering Europe’s Gene & Cell Therapy Startups
Marion Hitchcock, Managing Director of the Gene & Cell Therapies Incubator Berlin and R&D Strategy & Portfolio Manager a ... -
)
With the rise of allogeneic cell therapies, the cell and gene therapy industry stands at a potential turning point. In t ... -
)
As gene therapies expand their clinical development and therapeutic reach Biotech’s are always looking for better ways o ... -
)
In this in-depth interview with Genezen’s Founder and Executive Chairman, Bill Vincent, we unpack the evolving landscape ... -
)
Adeno-associated viral vectors have quickly become the vector of choice for many gene therapy developers. With a strong ... -
)
Over the past two decades, advanced therapies have transformed healthcare—from the first FDA-approved cell therapy to CR ...